IDEAYA Biosciences, Inc. Stock Analysis & AI Score
IDEAYA Biosciences, Inc. (IDYA) has an ST Score of 59.3 (B-), driven by its Profitability (A) and held back by its Growth (D). Analysts rate it Buy with a $57.00 price target (+55.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
IDEAYA Biosciences, Inc. (IDYA) has an ST Score of 59.3 (B-), driven by its Profitability (A) and held back by its Growth (D). Analysts rate it Buy with a $57.00 price target (+55.1% upside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthD
All factor grades
- ProfitabilityA
- MomentumA
- Financial StrengthA-
- ValuationB
- ForecastB
- GrowthD
- Piotroski2/9
Contact
IDYA stock: frequently asked questions
What is IDYA's ST Score?
IDEAYA Biosciences, Inc. (IDYA) has an ST Score of 59.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IDYA a buy, hold, or sell?
Analysts rate IDYA a Buy, with a price target of $57.00 (+55.1% vs the current price). Our ST Score grades it B- (59.3/100). The ST Score is a data-driven signal, not a recommendation.
What are IDYA's factor grades?
Valuation B, Profitability A, Financial Strength A-, Momentum A, Growth D, Forecast B.
What is IDYA's valuation grade?
IDEAYA Biosciences, Inc. (IDYA) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IDYA's growth grade?
IDEAYA Biosciences, Inc. (IDYA) earns a growth grade of D, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IDYA's profitability grade?
IDEAYA Biosciences, Inc. (IDYA) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IDYA's financial strength grade?
IDEAYA Biosciences, Inc. (IDYA) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IDYA?
The average analyst price target for IDEAYA Biosciences, Inc. (IDYA) is $57.00 from 26 analysts, which is +55.1% versus the recent price of $36.74.
What is IDYA's Piotroski score?
IDEAYA Biosciences, Inc. (IDYA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.